文献速递关节外科骨质疏松与代谢性骨病

2型糖尿病对初次全髋与全膝关节置换术后院内并发症及死亡率的影响

Effect of Type 2 Diabetes on In-Hospital Postoperative Complications and Mortality After Primary Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-07-05

基于西班牙全国出院数据库2010—2014年数据,按年份、年龄、性别及改良Elixhauser合并症指数匹配后比较2型糖尿病与非糖尿病患者的院内术后并发症和院内死亡率。2型糖尿病与全髋和全膝置换术后「任何院内术后并发症」及尿路感染发生率更高相关,全膝置换术后院内死亡率也更高。

要点

  • 全髋置换:糖尿病组尿路感染1.50% vs 非糖尿病组1.09%(P = .007),任何院内术后并发症9.68% vs 8.98%(P = .038)。
  • 全膝置换:糖尿病组术后贫血4.90% vs 4.53%(P = .040),尿路感染0.80% vs 0.53%(P = .025),任何院内术后并发症7.30% vs 6.76%(P = .014)。
  • 两种手术后糖尿病组平均住院时间均显著更长;全膝置换糖尿病组院内死亡率0.09% vs 0.02%(P = .002)。

核心结论

  • 本研究证实2型糖尿病患者关节置换术后院内术后并发症风险更高。
  • 院内术后并发症可能导致全膝置换患者死亡风险更高。

研究设计与样本

  • 分析西班牙全国出院数据库2010—2014年数据,纳入接受初次全髋置换(ICD-9-CM 81.51)和全膝置换(ICD-9-CM 81.54)的患者。
  • 按年份、年龄、性别及改良Elixhauser合并症指数所含合并症,将糖尿病与非糖尿病患者进行匹配。

主要发现

  • 共识别全髋置换患者115,234例、全膝置换患者195,355例,其中2型糖尿病分别占12.4%和15.6%。
  • 匹配全髋置换10,777对、全膝置换26,640对糖尿病与非糖尿病患者。
  • 全髋置换糖尿病组尿路感染发生率1.50% vs 非糖尿病组1.09%(P = .007),任何院内术后并发症9.68% vs 8.98%(P = .038)。
  • 全膝置换糖尿病组术后贫血4.90% vs 4.53%(P = .040),尿路感染0.80% vs 0.53%(P = .025),任何院内术后并发症7.30% vs 6.76%(P = .014)。
  • 两种手术中糖尿病组平均住院时间均显著更高;全膝置换糖尿病组院内死亡率0.09% vs 0.02%(P = .002)。

关键数值与推荐

  • 全髋置换糖尿病组尿路感染1.50% vs 非糖尿病组1.09%(P = .007)。
  • 全髋置换糖尿病组任何院内术后并发症9.68% vs 非糖尿病组8.98%(P = .038)。
  • 全膝置换糖尿病组术后贫血4.90% vs 非糖尿病组4.53%(P = .040)。
  • 全膝置换糖尿病组尿路感染0.80% vs 非糖尿病组0.53%(P = .025)。
  • 全膝置换糖尿病组任何院内术后并发症7.30% vs 非糖尿病组6.76%(P = .014);院内死亡率0.09% vs 0.02%(P = .002)。

临床怎么用

  • 既往合并症、年龄和肥胖可预测糖尿病患者院内术后并发症发生率更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to compare in-hospital postoperative complications (IHPC) and in-hospital mortality between patients with and without type 2 diabetes mellitus (T2DM) undergoing primary total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: We analyzed data from the Spanish National Hospital Discharge Database, 2010-2014. We selected patients who had undergone THA (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 81.51) and TKA (code 81.54). Diabetic patients with THA and TKA were matched by year, age, sex, and the comorbidities included in the modified Elixhauser Comorbidity Index with a nondiabetic patient. RESULTS: We identified 115,234 THA patients and 195,355 TKA patients, 12.4% and 15.6% with T2DM, respectively. We matched 10,777 and 26,640 pairs of diabetic and nondiabetic patients. In T2DM patients who had undergone THA, the incidence of urinary tract infection was higher than in nondiabetic patients (1.50% vs 1.09%, P = .007), as was that of "any IHPC" (9.68% vs 8.98%, P = .038). In patients who had undergone TKA, the incidence of postoperative anemia was significantly higher in diabetic patients (4.90% vs 4.53, P = .040), as was that of urinary tract infection (0.80% vs 0.53%, P = .025) and "any IHPC" (7.30% vs 6.76%, P = .014). In both procedures, mean length of hospital stay was significantly higher in diabetic patients; for TKA, in-hospital mortality was higher in diabetic patients (0.09% vs 0.02%, P = .002). Previous comorbidities, age, and obesity predict a higher incidence of IHPC among diabetic patients. CONCLUSIONS: This study confirms the higher risk of IHPC among T2DM patients after joint arthroplasty. IHPC may result in a higher risk of mortality in patients undergoing TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Martínez-Huedo MA, Jiménez-García R, Jiménez-Trujillo I, et al. Effect of Type 2 Diabetes on In-Hospital Postoperative Complications and Mortality After Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28735804. doi:10.1016/j.arth.2017.06.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。